The Stocks Wall Street Is Watching

The following stocks may be
impacted due to significant news as noted:

Networking company Cisco
Systems

(
CSCO |
Quote |
Chart |
News |
PowerRating)
has had its earnings estimates cut by UBS Warburg due to
a weaker than expected U.S. market. The firm maintains its "hold" rating with a
price target of $14.50. 

Drug stocks are in the news
today as Abbott Labs
(
ABT |
Quote |
Chart |
News |
PowerRating)
has received FDA approval for its
rheumatoid arthritis drug Humira. Keep an eye on Amgen
(
AMGN |
Quote |
Chart |
News |
PowerRating)
as it
may sell-off due to new competition.

Merck
(
MRK |
Quote |
Chart |
News |
PowerRating)
has
received FDA approval for its hay fever drug Singulair.

Bristol Myers
(
BMY |
Quote |
Chart |
News |
PowerRating)

is being reported by the New York Times as an ideal candidate for a takeover.

Conglomerate General
Electric

(
GE |
Quote |
Chart |
News |
PowerRating)
will be facing its first strike in 30 years, which will
hinder production in U.S. plants. Workers are reacting to a $200 increase in
payments towards the company’s managed healthcare plan.

Pre-market action:


(
ENMD |
Quote |
Chart |
News |
PowerRating)
+44%,
(
ERICY |
Quote |
Chart |
News |
PowerRating)

+8.5%,
(
AEOS |
Quote |
Chart |
News |
PowerRating)
+5%,
(
CHKP |
Quote |
Chart |
News |
PowerRating)
+4%,
(
AMAT |
Quote |
Chart |
News |
PowerRating)
+2.5%,
(
ABT |
Quote |
Chart |
News |
PowerRating)
+1.8%,
(
AMGN |
Quote |
Chart |
News |
PowerRating)

+0.8%,
(
CSCO |
Quote |
Chart |
News |
PowerRating)
+0.15%.


(
PMTC |
Quote |
Chart |
News |
PowerRating)
-25%,
(
RSTO |
Quote |
Chart |
News |
PowerRating)

-11%.